Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study
Background IL-15 levels are increased in serum, synovium and bone marrow of RA-patients. IL-15 influences both the innate and adaptive immune response; its major role is activation and proliferation of T cells. Data also emerge that IL-15 affects osteoclastogenesis. The authors investigated the asso...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2012-02, Vol.71 (Suppl 1), p.A56-A57 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A57 |
---|---|
container_issue | Suppl 1 |
container_start_page | A56 |
container_title | Annals of the rheumatic diseases |
container_volume | 71 |
creator | Knevel, R Krabben, A Brouwer, E Posthumus Wilson, A G Saxne, T Lindqvist, E de Rooy, D P C Daha, N A van der Linden, M P M Stoeken-Rijsbergen, G van Toorn, L Koeleman, B F C Tsonaka, S Zhernakova, A Houwing-Duistermaat, J J Toes, R E M Huizinga, T W J van der Helm-van Mil, A H M |
description | Background IL-15 levels are increased in serum, synovium and bone marrow of RA-patients. IL-15 influences both the innate and adaptive immune response; its major role is activation and proliferation of T cells. Data also emerge that IL-15 affects osteoclastogenesis. The authors investigated the association of genetic variants in IL-15 with rate of joint destruction in RA. Method 1418 patients with 4885 x-ray sets of both hands and feet of four independent datasets were studied. First, explorative analyses were performed on 600 early RA patients enrolled in the Leiden Early Arthritis Clinic. Twenty-five SNPs tagging IL-15 were tested. Second, SNPs with significant associations in the explorative phase were genotyped in datasets from Groningen, Sheffield and Lund. In each dataset the relative increase of the progression rate per year in the presence of a genotype was assessed. Subsequently, data were summarised in an inverse weighting meta-analysis. Results Five SNPs were significantly associated with rate of joint destruction in phase-1 and typed in the other datasets. Patients homozygous for rs7667746, rs7665842, rs2322182, rs6821171 and rs4371699 had respectively 0.94, 1.04, 1.09, 1.09 and 1.09 fold rate of joint destruction per year compared to other patients (p=4.0 × 10−6, p=3.8 × 10−4, p=5.0 × 10−3, p=5.0 × 10−3 and p=9.4 × 10−3). Due to insufficient power of the cohorts of phase-2, independent replication was not obtained. Meta-analyses of all datasets combined resulted in significant results for four SNPs (rs7667746, p |
doi_str_mv | 10.1136/annrheumdis-2011-201236.14 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777880910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008562971</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2154-59116f7e59d3e47585b4ca157ee3aa2bc0bec7383f46b6826a7687ee2c245fda3</originalsourceid><addsrcrecordid>eNqVUMtOIzEQtBBIhMc_WMt1B9zjZ7itoiUgRSAhHkfL4_EQZ8kYbA-Pv8dhENorl251dVV3qRD6BeQYgIoT0_dx6YZ161NVE4BNqak4BraFJsCEKoAg22hCCKEVmwq5i_ZSWpWRKFAT9Dp3vcve4hcTvelzwr7HF4sKODYpBetNdvjV5yV-iuEhupR86HHo8Cr4PuPWpRwHmzdgEX56MTn4FpuYl9Fnn35jg9fDY_bYhmWIGac8tO8HaKczj8kdfvV9dHv292Z2Xi2u5hezP4uqqYGzik8BRCcdn7bUMckVb5g1wKVz1Ji6saRxVlJFOyYaoWphpFBlWdua8a41dB8djXeL_eehuNWrMMS-vNQgpVSKTIEU1unIsjGkFF2nn6Jfm_iugehN0Pq_oPUmaD0GrYEVcTWKfcru7Vtp4j8tJJVcX97N9BmZc3p_TTQvfD7ym_XqJ38-AJX1luc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777880910</pqid></control><display><type>article</type><title>Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study</title><source>BMJ Journals - NESLi2</source><creator>Knevel, R ; Krabben, A ; Brouwer, E ; Posthumus ; Wilson, A G ; Saxne, T ; Lindqvist, E ; de Rooy, D P C ; Daha, N A ; van der Linden, M P M ; Stoeken-Rijsbergen, G ; van Toorn, L ; Koeleman, B F C ; Tsonaka, S ; Zhernakova, A ; Houwing-Duistermaat, J J ; Toes, R E M ; Huizinga, T W J ; van der Helm-van Mil, A H M</creator><creatorcontrib>Knevel, R ; Krabben, A ; Brouwer, E ; Posthumus ; Wilson, A G ; Saxne, T ; Lindqvist, E ; de Rooy, D P C ; Daha, N A ; van der Linden, M P M ; Stoeken-Rijsbergen, G ; van Toorn, L ; Koeleman, B F C ; Tsonaka, S ; Zhernakova, A ; Houwing-Duistermaat, J J ; Toes, R E M ; Huizinga, T W J ; van der Helm-van Mil, A H M</creatorcontrib><description>Background IL-15 levels are increased in serum, synovium and bone marrow of RA-patients. IL-15 influences both the innate and adaptive immune response; its major role is activation and proliferation of T cells. Data also emerge that IL-15 affects osteoclastogenesis. The authors investigated the association of genetic variants in IL-15 with rate of joint destruction in RA. Method 1418 patients with 4885 x-ray sets of both hands and feet of four independent datasets were studied. First, explorative analyses were performed on 600 early RA patients enrolled in the Leiden Early Arthritis Clinic. Twenty-five SNPs tagging IL-15 were tested. Second, SNPs with significant associations in the explorative phase were genotyped in datasets from Groningen, Sheffield and Lund. In each dataset the relative increase of the progression rate per year in the presence of a genotype was assessed. Subsequently, data were summarised in an inverse weighting meta-analysis. Results Five SNPs were significantly associated with rate of joint destruction in phase-1 and typed in the other datasets. Patients homozygous for rs7667746, rs7665842, rs2322182, rs6821171 and rs4371699 had respectively 0.94, 1.04, 1.09, 1.09 and 1.09 fold rate of joint destruction per year compared to other patients (p=4.0 × 10−6, p=3.8 × 10−4, p=5.0 × 10−3, p=5.0 × 10−3 and p=9.4 × 10−3). Due to insufficient power of the cohorts of phase-2, independent replication was not obtained. Meta-analyses of all datasets combined resulted in significant results for four SNPs (rs7667746, p<0.001; rs7665842, p<0.001; rs4371699 p=0.01; rs6821171, p=0.01). These SNPs were also significant after correction for multiple testing. Conclusion Genetic variants in IL-15 are associated with progression of joint destruction in RA.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2011-201236.14</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2012-02, Vol.71 (Suppl 1), p.A56-A57</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/71/Suppl_1/A56.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/71/Suppl_1/A56.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77343,77374</link.rule.ids></links><search><creatorcontrib>Knevel, R</creatorcontrib><creatorcontrib>Krabben, A</creatorcontrib><creatorcontrib>Brouwer, E</creatorcontrib><creatorcontrib>Posthumus</creatorcontrib><creatorcontrib>Wilson, A G</creatorcontrib><creatorcontrib>Saxne, T</creatorcontrib><creatorcontrib>Lindqvist, E</creatorcontrib><creatorcontrib>de Rooy, D P C</creatorcontrib><creatorcontrib>Daha, N A</creatorcontrib><creatorcontrib>van der Linden, M P M</creatorcontrib><creatorcontrib>Stoeken-Rijsbergen, G</creatorcontrib><creatorcontrib>van Toorn, L</creatorcontrib><creatorcontrib>Koeleman, B F C</creatorcontrib><creatorcontrib>Tsonaka, S</creatorcontrib><creatorcontrib>Zhernakova, A</creatorcontrib><creatorcontrib>Houwing-Duistermaat, J J</creatorcontrib><creatorcontrib>Toes, R E M</creatorcontrib><creatorcontrib>Huizinga, T W J</creatorcontrib><creatorcontrib>van der Helm-van Mil, A H M</creatorcontrib><title>Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background IL-15 levels are increased in serum, synovium and bone marrow of RA-patients. IL-15 influences both the innate and adaptive immune response; its major role is activation and proliferation of T cells. Data also emerge that IL-15 affects osteoclastogenesis. The authors investigated the association of genetic variants in IL-15 with rate of joint destruction in RA. Method 1418 patients with 4885 x-ray sets of both hands and feet of four independent datasets were studied. First, explorative analyses were performed on 600 early RA patients enrolled in the Leiden Early Arthritis Clinic. Twenty-five SNPs tagging IL-15 were tested. Second, SNPs with significant associations in the explorative phase were genotyped in datasets from Groningen, Sheffield and Lund. In each dataset the relative increase of the progression rate per year in the presence of a genotype was assessed. Subsequently, data were summarised in an inverse weighting meta-analysis. Results Five SNPs were significantly associated with rate of joint destruction in phase-1 and typed in the other datasets. Patients homozygous for rs7667746, rs7665842, rs2322182, rs6821171 and rs4371699 had respectively 0.94, 1.04, 1.09, 1.09 and 1.09 fold rate of joint destruction per year compared to other patients (p=4.0 × 10−6, p=3.8 × 10−4, p=5.0 × 10−3, p=5.0 × 10−3 and p=9.4 × 10−3). Due to insufficient power of the cohorts of phase-2, independent replication was not obtained. Meta-analyses of all datasets combined resulted in significant results for four SNPs (rs7667746, p<0.001; rs7665842, p<0.001; rs4371699 p=0.01; rs6821171, p=0.01). These SNPs were also significant after correction for multiple testing. Conclusion Genetic variants in IL-15 are associated with progression of joint destruction in RA.</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqVUMtOIzEQtBBIhMc_WMt1B9zjZ7itoiUgRSAhHkfL4_EQZ8kYbA-Pv8dhENorl251dVV3qRD6BeQYgIoT0_dx6YZ161NVE4BNqak4BraFJsCEKoAg22hCCKEVmwq5i_ZSWpWRKFAT9Dp3vcve4hcTvelzwr7HF4sKODYpBetNdvjV5yV-iuEhupR86HHo8Cr4PuPWpRwHmzdgEX56MTn4FpuYl9Fnn35jg9fDY_bYhmWIGac8tO8HaKczj8kdfvV9dHv292Z2Xi2u5hezP4uqqYGzik8BRCcdn7bUMckVb5g1wKVz1Ji6saRxVlJFOyYaoWphpFBlWdua8a41dB8djXeL_eehuNWrMMS-vNQgpVSKTIEU1unIsjGkFF2nn6Jfm_iugehN0Pq_oPUmaD0GrYEVcTWKfcru7Vtp4j8tJJVcX97N9BmZc3p_TTQvfD7ym_XqJ38-AJX1luc</recordid><startdate>201202</startdate><enddate>201202</enddate><creator>Knevel, R</creator><creator>Krabben, A</creator><creator>Brouwer, E</creator><creator>Posthumus</creator><creator>Wilson, A G</creator><creator>Saxne, T</creator><creator>Lindqvist, E</creator><creator>de Rooy, D P C</creator><creator>Daha, N A</creator><creator>van der Linden, M P M</creator><creator>Stoeken-Rijsbergen, G</creator><creator>van Toorn, L</creator><creator>Koeleman, B F C</creator><creator>Tsonaka, S</creator><creator>Zhernakova, A</creator><creator>Houwing-Duistermaat, J J</creator><creator>Toes, R E M</creator><creator>Huizinga, T W J</creator><creator>van der Helm-van Mil, A H M</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201202</creationdate><title>Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study</title><author>Knevel, R ; Krabben, A ; Brouwer, E ; Posthumus ; Wilson, A G ; Saxne, T ; Lindqvist, E ; de Rooy, D P C ; Daha, N A ; van der Linden, M P M ; Stoeken-Rijsbergen, G ; van Toorn, L ; Koeleman, B F C ; Tsonaka, S ; Zhernakova, A ; Houwing-Duistermaat, J J ; Toes, R E M ; Huizinga, T W J ; van der Helm-van Mil, A H M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2154-59116f7e59d3e47585b4ca157ee3aa2bc0bec7383f46b6826a7687ee2c245fda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knevel, R</creatorcontrib><creatorcontrib>Krabben, A</creatorcontrib><creatorcontrib>Brouwer, E</creatorcontrib><creatorcontrib>Posthumus</creatorcontrib><creatorcontrib>Wilson, A G</creatorcontrib><creatorcontrib>Saxne, T</creatorcontrib><creatorcontrib>Lindqvist, E</creatorcontrib><creatorcontrib>de Rooy, D P C</creatorcontrib><creatorcontrib>Daha, N A</creatorcontrib><creatorcontrib>van der Linden, M P M</creatorcontrib><creatorcontrib>Stoeken-Rijsbergen, G</creatorcontrib><creatorcontrib>van Toorn, L</creatorcontrib><creatorcontrib>Koeleman, B F C</creatorcontrib><creatorcontrib>Tsonaka, S</creatorcontrib><creatorcontrib>Zhernakova, A</creatorcontrib><creatorcontrib>Houwing-Duistermaat, J J</creatorcontrib><creatorcontrib>Toes, R E M</creatorcontrib><creatorcontrib>Huizinga, T W J</creatorcontrib><creatorcontrib>van der Helm-van Mil, A H M</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knevel, R</au><au>Krabben, A</au><au>Brouwer, E</au><au>Posthumus</au><au>Wilson, A G</au><au>Saxne, T</au><au>Lindqvist, E</au><au>de Rooy, D P C</au><au>Daha, N A</au><au>van der Linden, M P M</au><au>Stoeken-Rijsbergen, G</au><au>van Toorn, L</au><au>Koeleman, B F C</au><au>Tsonaka, S</au><au>Zhernakova, A</au><au>Houwing-Duistermaat, J J</au><au>Toes, R E M</au><au>Huizinga, T W J</au><au>van der Helm-van Mil, A H M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2012-02</date><risdate>2012</risdate><volume>71</volume><issue>Suppl 1</issue><spage>A56</spage><epage>A57</epage><pages>A56-A57</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background IL-15 levels are increased in serum, synovium and bone marrow of RA-patients. IL-15 influences both the innate and adaptive immune response; its major role is activation and proliferation of T cells. Data also emerge that IL-15 affects osteoclastogenesis. The authors investigated the association of genetic variants in IL-15 with rate of joint destruction in RA. Method 1418 patients with 4885 x-ray sets of both hands and feet of four independent datasets were studied. First, explorative analyses were performed on 600 early RA patients enrolled in the Leiden Early Arthritis Clinic. Twenty-five SNPs tagging IL-15 were tested. Second, SNPs with significant associations in the explorative phase were genotyped in datasets from Groningen, Sheffield and Lund. In each dataset the relative increase of the progression rate per year in the presence of a genotype was assessed. Subsequently, data were summarised in an inverse weighting meta-analysis. Results Five SNPs were significantly associated with rate of joint destruction in phase-1 and typed in the other datasets. Patients homozygous for rs7667746, rs7665842, rs2322182, rs6821171 and rs4371699 had respectively 0.94, 1.04, 1.09, 1.09 and 1.09 fold rate of joint destruction per year compared to other patients (p=4.0 × 10−6, p=3.8 × 10−4, p=5.0 × 10−3, p=5.0 × 10−3 and p=9.4 × 10−3). Due to insufficient power of the cohorts of phase-2, independent replication was not obtained. Meta-analyses of all datasets combined resulted in significant results for four SNPs (rs7667746, p<0.001; rs7665842, p<0.001; rs4371699 p=0.01; rs6821171, p=0.01). These SNPs were also significant after correction for multiple testing. Conclusion Genetic variants in IL-15 are associated with progression of joint destruction in RA.</abstract><cop>Kidlington</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2011-201236.14</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2012-02, Vol.71 (Suppl 1), p.A56-A57 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1777880910 |
source | BMJ Journals - NESLi2 |
title | Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T20%3A58%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20variants%20in%20IL-15%20associate%20with%20progression%20of%20joint%20destruction%20in%20rheumatoid%20arthritis,%20a%20multi%20cohort%20study&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Knevel,%20R&rft.date=2012-02&rft.volume=71&rft.issue=Suppl%201&rft.spage=A56&rft.epage=A57&rft.pages=A56-A57&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2011-201236.14&rft_dat=%3Cproquest_cross%3E4008562971%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777880910&rft_id=info:pmid/&rfr_iscdi=true |